Soups and shakes diet ‘can put type 2 diabetes into remission’ – study
People who took part in the NHS programme lost a significant amount of weight.
An NHS “soups and shakes” diet can help swathes of people with type 2 diabetes put their condition “in remission”, experts have said.
A new study found that people who embark on the diet and lifestyle programme can shed a significant amount of weight.
And almost a third can put their type 2 diabetes in remission, according to a new paper published in the journal Lancet Diabetes and Endocrinology.
The year-long programme helps people kick-start their weight loss journey with a low calorie “meal replacement” diet of soups, shakes and bars for the first 12 weeks.
People are then encouraged to reintroduce healthy food and are supported to maintain their weight loss.
NHS England said that the paper shows that its Type 2 Diabetes Path to Remission programme could benefit “thousands” of people with the condition.
It was announced earlier this year that the initiative will be rolled out across the whole of England this year, doubling the capacity of the programme.
The new study examined data on 7,540 people who took part in the programme between September 2020 and the end of 2022.
Of these, some 945 completed a full year of the programme and had provided blood samples.
Among this group, 32% had put their condition into remission – which was defined by average blood glucose (sugar) levels over a period of time, with an average weight loss of 15.9kg – with some achieving weight loss of up to 17.4kg.
Dr Clare Hambling, NHS England’s national clinical director for diabetes and obesity, said: “The NHS Type 2 Diabetes Path to Remission Programme can have a huge impact on the lives of participants, and it’s brilliant that these findings show a large number of those who completed it have seen life-changing benefits including major weight loss and type 2 diabetes remission.
“We know obesity is one of the biggest threats to health in the UK and will be one of the biggest and most costly challenges for health systems globally, so seeing such encouraging outcomes from our programme shows that obesity can be tackled head-on, and we’re looking forward to scoping any further expansion to this programme in due course.”
Commenting on the study, Dr Elizabeth Robertson, director of research at Diabetes UK, said: “Diabetes UK is proud to have funded over a decade of research that has forged new frontiers for people with type 2 diabetes and put remission on the map.
“These latest findings add to the real world evidence that the NHS England Type 2 Diabetes Path to Remission Programme can help thousands of people living with type 2 diabetes on their weight loss and remission journey, which we know is tough and having support is critical.
“We hope to see even more people benefiting in years to come and an increase in referrals to the programme especially for people recently diagnosed with type 2 diabetes and in younger people where the impact of type 2 diabetes and remission from it is greatest.”
Over 25,000 people have already embarked in the programme since it was first launched in 2020 and officials in England are ploughing £13 million into the programme this year to ensure that more people can benefit.
Adults aged 18-65 can enrol on the programme is they have been diagnosed with type 2 diabetes in the last six years and if they have a body mass index score of over 27 if they are white or over 25 if they are from Black, Asian or other minority ethnic groups.
